Chiropractors in Sebewaing, MI Accepting Medicare
5 Chiropractors found. Showing 1 - 5
 Ryan Schwartz, DC, BS Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 8844 Unionville Rd, Sebewaing, MI 48759 Phone: 989-770-3909 |
Richard James Rivers, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1 N Center St, Sebewaing, MI 48759 Phone: 989-883-9090 Fax: 989-883-2132 |
 Dr. Whitney Lorraine Schulz, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 211 N Center St, Sebewaing, MI 48759 Phone: 989-704-3334 |
 3 Point Chiropractic Corp Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 211 N Center St, Sebewaing, MI 48759 Phone: 989-704-3334 |
Aaron L. Rackham D.c., Pc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1 N Center St, Sebewaing, MI 48759 Phone: 989-883-9090 Fax: 989-883-2375 |
News Archive
Drug sellers, benefit managers poise for court-ordered price cuts
"A forthcoming rollback of benchmark drug prices - a court-approved move meant to benefit consumers - should have little effect on the bottom line for pharmacy-benefit managers or their clients, as companies have taken protective steps," the Wall Street Journal reports. Pharmacies, however, worry the 4 percent reduction in benchmark prices could result in Medicaid reductions. Benefit managers initially opposed the cut, but say they have adjusted contracts to make up for it.
FDA approves St. Jude Medical's Assura family of implantable defibrillators
St. Jude Medical, Inc., a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval of its Assura portfolio of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).
First patient enrolled in study evaluating S.M.A.R.T. Nitinol self-expandable stent
Cordis Corporation has announced the first patient enrollment in the STROLL trial, which will evaluate the safety and efficacy of the S.M.A.R.T. Nitinol Self-Expandable Stent System in treating patients with obstructive superficial femoral artery (SFA) disease, also known as SFA atherosclerosis.
Designing a prototype spike protein vaccine for SARS-CoV-2
A recent study published on the preprint server bioRxiv in June 2020 reports the development of a prototype vaccine containing multiple antigenic sites, based on the spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that is causing the current COVID-19 pandemic. If successful, this could lead to the development of an effective, non-allergenic vaccine that induces both humoral and cellular immunity.
GSA receives renewed grant support to advance reporters' coverage of aging issues
The Gerontological Society of America (GSA) has received renewed grant support to welcome a new cohort of reporters for the Journalists in Aging Fellows Program.
› Verified 7 days ago